Interview: Christopher Tsai, Chairman, Bionet, Taiwan
The chairman of Bionet reflects on past market challenges and the growing strength of Bionet’s reach both domestically and globally, and why Taiwan is the perfect size for a biotech…
Address: 7th floor, No. 69, Lane 77, Xing-Ai Road, Neihu, Taipei,Taiwan
Tel: +886 2 2790 0799
Web: http://www.chifupharma.com/
Chi-Fu Trading Co., Ltd. provides turnkey solutions to manufacturers worldwide who are interested in entering the Taiwanese and Asian markets. Chi-Fu carefully researchs the markets, and communicates with customers. Chi-Fu also evaluates potential products for our clients in the Asian markets. With the combined efforts of manufacturers and our marketing staff, Chi-Fu improves the health of the citizens and enhances its suppliers’ market portfolios.
Chi-Fu Trading Co., Ltd. Will transform from its existing stage into “Chi-Fu Multinational Enterprise” to better reflect our market representations as well as our diverse product lines.
We stride to become a leader in distributing highly sophisticated medical equipment, devices, pharmaceuticals, consumables and bio technology related products.
We will hold leadership positions in all of our product and service areas and become the leader in all of the markets that we are present.
Chi-Fu will engage and become a leader in the health promotion service and hospital management consultation, working toward improving the health care of mankind.
The chairman of Bionet reflects on past market challenges and the growing strength of Bionet’s reach both domestically and globally, and why Taiwan is the perfect size for a biotech…
Taiwan’s current health minister reflects on Taiwan’s prestigious healthcare system, the problems in the first generation health insurance system that were fixed in the second, and strategies to rectify the…
Jaw-Jou Kang, former Director General of Taiwan Food & Drug Administration (TFDA) discusses the key successes the company has had since 2010, where it is looking to in the future…
The Deputy Executive Secretary of Taiwan’s National Development Fund discusses the recent shift in focus from semiconductors to biotech investments; why this has been a huge success thus far and…
The Vice President of Merits Health Products discusses the company’s main opportunities and challenges of the past 25 years, which countries are among its top buyers and its future plans…
Over the past decade since its founding, what are some of the highlights in the transformation of Taiwan Advance Bio-Pharmaceutical Inc. (TABP) into a well established company? TABP was founded…
YFY Biotech Management Company has not always been involved in the biotech sector. How has it evolved over the years? Yuen Foong Yu Group originally began as a paper mill…
Dr. Chen, you joined US-based Anchen Pharmaceuticals in 2009 to help the company form a spin-off in Taiwan. Why did a US-based company look to establish itself in Taiwan, and…
Mr. Lin, you enjoyed a decades-long career in the ICT industry before making the transition to healthcare. What can you tell our readers about the evolution of General Biologics Corp.…
Formosa Laboratories is one of Taiwan’s international pioneers in small molecules, entering the global arena at a very early stage. How did that decision come about? Generally speaking, Taiwan’s API…
PAREXEL has been in Asia Pacific (APAC) since the company entered Japan in 1995. It chose Taiwan as its regional base of operations with the 2007 acquisition of APEX, a…
The managing director of Burrill & Company discusses the biotech industry in Taiwan, the various hurdles the market faces and why there is so much potential for industry growth in…
See our Cookie Privacy Policy Here
